Company: Solarvest Bioenergy Inc.
Listing : TSX Venture,Frankfurt
Ticker: SVS.V , 0ZJ:FRA
Market cap at time of publication: $6.64 MCAD
Stock price at time of publication: $0.12 CAD
Business: Patented plant based pharmaceuticals from algaes and Clean Energy Hydrogen production
Comparable peers: Else Nutrition market cap : 306 MCAD
Website:http://www.solarvest.ca/ and for the omega 3 products: https://eversea.ca/
ESGFIRE comment: Less than 2 months ago Solarvest announced they would be launching products in Asia and the United states through their partner OrgHive which have 23 million users online they have now announced that their products have been launched on OrgHive’s e-commerce platform for customers in Southeast Asia. Details about the partnership have been described before. Solarvest describes the launch as follows ” The OrgHive/Eversea site has also been translated to Chinese for the convenience of OrgHive’s 23 million unique organic-oriented customers. Customers in China can now access detailed information on the world’s first organic certified DHA product along with the chemical-free, clean label messaging. The e-commerce portal has also been configured and implemented. “
The press release states further” In addition, OrgHive and Eversea have developed a messaging program to promote/educate customers, on popular Chinese social media platforms, about the advantages of organic certified algae Omega-3. Fish oil is an established category and until now there has been no alternative that provides the assurance of product(s) that avoid environmental contamination and industrial chemical processing. The messages are designed to promote organic algae as a superior source of Omega-3, the importance of Omega-3 for brain health/growth, and general education on the types of Omega-3 with emphasis on the superior nature of long-chain Omega-3 (e.g. ALA vs. DHA). “
The sales potential on the OrghHive platform is clearly massive. A previous calculation by ESGFIRE has shown that if Solarvest attracts ONLY 0.1 % of the customer base (23000 customers buying 12 bottles a year at 20 USD per bottle) this could equal 5.5 million USD in annual sales.The company has clearly been working fast in order to get this product launch going as fast as possible and it will be very exciting to follow the progress which could have immense implications for the evaluation of Solarvest which is currently sitting on a market cap of just 6.64 MCAD!
Link to website: https://eversea.orghive.com/
About OrgHive
The OrgHive organic community has garnered 23 million unique users since inception last year. They provide organic related content to consumers online and have developed a blockchain-based verification system for organic products that are purchased throughout mainland China. Furthermore, the platform developed by OrgHive will reach organic consumers beyond China, including those located in other parts of Asia. There are no commercial or regulatory barriers for Ever-sea to sell its products to Chinese consumers through OrgHive’s online platform.
OrgHive will promote Eversea’s algae-based, certified organic Omega-3 DHA, the first of its kind in the world, to millions of its registered subscribers. OrgHive will be responsible for logistics, fulfillment and all digital marketing activities, including social media.
About Solarvest
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The Company has successfully developed, patented and produced the world’s only plant-based organic certified Omega-3 to satisfy the substantial demand for this essential nutrient. The Company has also initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.
Legal Disclaimer
We own shares of this company personally.
Investing in stocks is combined with certain risks and it is possible to lose your entire investment. Our posts are made for Educational purposes only and are not to be interpreted as tips , financial advice or recommendations of any kind to either buy or sell any stocks.
Companies may or may not be paying us for content posted on this website.
